Literature DB >> 35479637

Changes in the Profile of Fecal Microbiota and Metabolites as Well as Serum Metabolites and Proteome After Dietary Inulin Supplementation in Dairy Cows With Subclinical Mastitis.

Yue Wang1,2, Xuemei Nan1, Yiguang Zhao1, Linshu Jiang3, Hui Wang1, Fan Zhang1, Dengke Hua1, Jun Liu4, Liang Yang1, Junhu Yao2, Benhai Xiong1.   

Abstract

The occurrence and development of mastitis is linked to dysbiostic gastrointestinal microbiota. Inulin is a dietary prebiotic that improves the profile of intestinal flora. Our previous study showed that inulin supplementation could improve the ruminal microbes of subclinical mastitis (SCM) cows. The current study attempted to further investigate the response of hindgut (fecal) microbiome and metabolites, serum metabolism, and protein expression to inulin in the in SCM cows. Different levels of inulin (0, 100, 200, 300, and 400 g/day per cow) were supplemented in SCM cows. Compared with control group, Bacteroides and Bifidobacteria were increased, and Paeniclostridium, Ruminococcaceae, Coprococcus, and Clostridia were decreased in the feces of inulin groups, and accompanied with elevated propionate and butyrate concentrations, while secondary bile acid (SBA) metabolites were increased and proinflammatory lipid oxidation products were dropped in both feces and serum. In serum, inulin intake suppressed the levels of triglyceride (TG) and low-density lipoprotein (LDL). Serum proteome analysis found that CD44 antigen, phosphatidylinositol-glycan-specific phospholipase D, apolipoprotein A-II, and superoxide dismutase [Cu-Zn] were upregulated, while cathelicidin-1, haptoglobin, serpin A3, inter-alpha-trypsin inhibitor heavy chain H4 were downregulated in inulin groups. These findings suggested further evidence for inulin supplementation in amelioration of inflammatory symptoms in SCM cows, which might provide alternative treatment for mastitis.
Copyright © 2022 Wang, Nan, Zhao, Jiang, Wang, Zhang, Hua, Liu, Yang, Yao and Xiong.

Entities:  

Keywords:  dairy cows; fecal microbiota; inulin; metabolomics; serum proteome; subclinical mastitis

Year:  2022        PMID: 35479637      PMCID: PMC9037088          DOI: 10.3389/fmicb.2022.809139

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   6.064


  65 in total

1.  Arabinoxylans and inulin differentially modulate the mucosal and luminal gut microbiota and mucin-degradation in humanized rats.

Authors:  Pieter Van den Abbeele; Philippe Gérard; Sylvie Rabot; Aurélia Bruneau; Sahar El Aidy; Muriel Derrien; Michiel Kleerebezem; Erwin G Zoetendal; Hauke Smidt; Willy Verstraete; Tom Van de Wiele; Sam Possemiers
Journal:  Environ Microbiol       Date:  2011-08-30       Impact factor: 5.491

Review 2.  Role of the gut microbiota in immunity and inflammatory disease.

Authors:  Nobuhiko Kamada; Sang-Uk Seo; Grace Y Chen; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2013-05       Impact factor: 53.106

3.  Alistipes inops sp. nov. and Coprobacter secundus sp. nov., isolated from human faeces.

Authors:  Andrei N Shkoporov; Andrei V Chaplin; Ekaterina V Khokhlova; Victoria A Shcherbakova; Oksana V Motuzova; Vladimir K Bozhenko; Lyudmila I Kafarskaia; Boris A Efimov
Journal:  Int J Syst Evol Microbiol       Date:  2015-12       Impact factor: 2.747

4.  Determinants of plasma platelet-activating factor acetylhydrolase: heritability and relationship to plasma lipoproteins.

Authors:  R Guerra; B Zhao; V Mooser; D Stafforini; J M Johnston; J C Cohen
Journal:  J Lipid Res       Date:  1997-11       Impact factor: 5.922

5.  Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.

Authors:  Thomas Hagan; Mario Cortese; Nadine Rouphael; Carolyn Boudreau; Caitlin Linde; Mohan S Maddur; Jishnu Das; Hong Wang; Jenna Guthmiller; Nai-Ying Zheng; Min Huang; Amit A Uphadhyay; Luiz Gardinassi; Caroline Petitdemange; Michele Paine McCullough; Sara Jo Johnson; Kiran Gill; Barbara Cervasi; Jun Zou; Alexis Bretin; Megan Hahn; Andrew T Gewirtz; Steve E Bosinger; Patrick C Wilson; Shuzhao Li; Galit Alter; Surender Khurana; Hana Golding; Bali Pulendran
Journal:  Cell       Date:  2019-09-05       Impact factor: 41.582

6.  ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection.

Authors:  M Piñeiro; M Andrés; M Iturralde; S Carmona; J Hirvonen; S Pyörälä; P M H Heegaard; K Tjørnehøj; F Lampreave; A Piñeiro; M A Alava
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

7.  The gut microbiota contributes to the development of Staphylococcus aureus-induced mastitis in mice.

Authors:  Xiaoyu Hu; Jian Guo; Caijun Zhao; Peng Jiang; T Maimai; Li Yanyi; Yongguo Cao; Yunhe Fu; Naisheng Zhang
Journal:  ISME J       Date:  2020-04-27       Impact factor: 10.302

8.  Impact of the microbial derived short chain fatty acid propionate on host susceptibility to bacterial and fungal infections in vivo.

Authors:  Eleonora Ciarlo; Tytti Heinonen; Jacobus Herderschee; Craig Fenwick; Matteo Mombelli; Didier Le Roy; Thierry Roger
Journal:  Sci Rep       Date:  2016-11-29       Impact factor: 4.379

9.  Associations of serum indolepropionic acid, a gut microbiota metabolite, with type 2 diabetes and low-grade inflammation in high-risk individuals.

Authors:  Marjo Tuomainen; Jaana Lindström; Marko Lehtonen; Seppo Auriola; Jussi Pihlajamäki; Markku Peltonen; Jaakko Tuomilehto; Matti Uusitupa; Vanessa D de Mello; Kati Hanhineva
Journal:  Nutr Diabetes       Date:  2018-05-25       Impact factor: 5.097

10.  Rumen microbiome structure and metabolites activity in dairy cows with clinical and subclinical mastitis.

Authors:  Yue Wang; Xuemei Nan; Yiguang Zhao; Linshu Jiang; Mengling Wang; Hui Wang; Fan Zhang; Fuguang Xue; Dengke Hua; Jun Liu; Junhu Yao; Benhai Xiong
Journal:  J Anim Sci Biotechnol       Date:  2021-02-08
View more
  1 in total

1.  Gill Junction Injury and Microbial Disorders Induced by Microcystin-Leucine Arginine in Lithobates catesbeianus Tadpoles.

Authors:  Huiling Jiang; Jun He; Hui Wang; Lingling Zheng; Xiaoran Wang; Huijuan Zhang; Hailong Wu; Yilin Shu
Journal:  Toxins (Basel)       Date:  2022-07-13       Impact factor: 5.075

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.